Study Evaluating AMG 386 in Adult Patients With Advanced Solid Tumors
NCT00102830
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Tumors
Interventions
DRUG:
AMG 386
Sponsor
Amgen